Polybiomics
Menlo Park, US · Founded 2017 · Delaware corporation
Polybiomics develops a live cell analysis platform that measures multiple phenotypes and functions of cells simultaneously and continuously without disrupting them or their 3D environments. The system combines a bioinstrument, consumable, and the PolyData analytics engine with AI to interpret multimodal datasets for research, pharmaceutical, biomanufacturing, and clinical workflows.
Founders & leadership
Polybiomics was founded in 2017 by Bahram Bahrami.
BB
Bahram BahramiCo-founder & CEO
SB
S. Bahram BahramiChief Executive Officer
MV
Mandana VeisehFounder, President, CSTO
Reported raises · per SEC filings
Form D private placements$2.5M disclosed across 1 round · 2017
▶$2.5MraisedApr 2017 · 2 investors · BiotechnologyRule 506(b)
▶$2.5MraisedApr 2017 · 2 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Mandana VeisehExecutive Officer
- S. Bahram BahramiExecutive Officer, Director
- Offering amount
- $2.5M
- Amount sold
- $2.5M
- First sale
- Mar 2017
- Incorporated
- Corporation, Delaware, 2017
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
In the news
Frequently asked questions
- What does Polybiomics do?
- Polybiomics develops a live cell analysis platform that measures multiple phenotypes and functions of cells simultaneously and continuously without disrupting them or their 3D environments. The system combines a bioinstrument, consumable, and the PolyData analytics engine with AI to interpret multimodal datasets for research, pharmaceutical, biomanufacturing, and clinical workflows.
- Who founded Polybiomics?
- Polybiomics was founded by Bahram Bahrami in 2017.
- How much funding has Polybiomics raised?
- Polybiomics has disclosed $2.5M raised across 1 round.
- Where is Polybiomics headquartered?
- Polybiomics is headquartered in Menlo Park, US.